Atherogenic dislipoproteinemia; metabolic syndrome; chronic fatigue syndrome

Biostimulatory medicines favorable to implicating both stem and immunocompetent cell in regenerative processes are injected according to the devised schedule. The treatment is conducted on an outpatient basis and takes 14-to-21 days.

An increase of regenerative cellular activity in internal organs normalizes metabolic processes occurring in the body.

The therapy is based in administrating the natural biostimulatory medicines that have no serious harmful side effects.

Regenerative immunotherapy for age-related, metabolic abnormalities

The age-related metabolic abnormalities are the heralds of severe diseases. The regenerative immunotherapy, aimed at implicating endogenous stem cells in regenerative processes and at creating favorable conditions for the realization of their regenerative potential, is able to inhibit the development of degenerate changes in body’s tissues, and, thereby, delaying the development of age-related diseases. According to our own experience, the regenerative immunotherapy is an effective treatment for age-specific, metabolic abnormalities. It should be pointed out, however, that benefits from this therapy vary in different patients from minimal to strongly pronounced, and that they last, as a rule, not longer than 1 year. On the other hand, the repeated course of the treatment can be not less effective than the first one. Thus, the regenerative immunotherapy may be one of feasible way to delay the development of age-related diseases, and to attain maximal human longevity.